Compare CVS Health Corp (CVS) vs Riot Platforms Inc (RIOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Riot Platforms Inc — how do they compare? CVS Health Corp trades at $86.16 (market cap $112.29B), while Riot Platforms Inc trades at $16.89 (market cap $6.32B). The key difference: CVS Health Corp is far larger — about 17.8× Riot Platforms Inc's market cap, and CVS Health Corp pays a 3.03% dividend while Riot Platforms Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Riot Platforms Inc for 16 Days on average.
| CVS | RIOT | |
|---|---|---|
Market Cap | $112.29B | $6.32B |
Volume | 7,763,676 | 30,571,756 |
Sector | Health | Financials |
52-Week High | $110.60 | $28.67 |
52-Week Low | $70.08 | $11.83 |
Typical Hold Time | 83 Days | 16 Days |
Enterprise Value | $174.64B | $6.73B |
Dividend Yield | 3.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, down 0.17% with a bearish technical signal. The company shows strong revenue growth to $402.1B in 2025 and has beaten earnings estimates for three consecutive quarters. Analyst consensus is overwhelmingly bullish with 85% buy ratings and a $111.20 price target representing 27% upside. Recent news highlights Aetna's 2027 Medicare plan enhancements and quarterly dividend declarations.
CVS presents a compelling value opportunity with attractive valuation metrics (P/E 23.17, P/S 0.27) and strong analyst support. Key risks include reimbursement pressure, regulatory scrutiny from ongoing investigations, and declining net margins. The stock's current technical weakness contrasts with solid fundamentals and positive earnings momentum.
RIOT Platforms trades at $16.84, down 9.17% with bearish technical signals despite strong analyst support. The company shows concerning fundamentals with negative net income margin of -196.28% and consistent earnings misses, though revenue grew to $647M in 2025. Recent strategic pivot to data center operations with $9.8B in contracted lease revenue through 2048 provides long-term visibility.
While analyst consensus remains strongly bullish with $31.64 price target, investors face significant execution risks amid persistent losses and competitive pressures. The stock's current valuation appears stretched given profitability challenges, requiring careful monitoring of the AI infrastructure transition's success.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Riot Platforms Inc
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →
